KindeI et al. (2011) :Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci USA.108(23):9530–5.
Jeanne Tie et al.(2016):Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.Science Translational MedicineJ.8(346):346-92.
Rodriguez et al.(2019):Detection of TP53 and PIK3CA mutations in circulating tumor DNA using Next-Generation Sequencing in the screening process for early breast cancer diagnosis. J. Clin. Medicine.8(8):1183